Health Equity Vision into Action Report
Learn how identifying and addressing disparities in healthcare allows everyone to live their healthiest life.
Addressing pharmacy issues that matter to you
From specialty pharmacy to drug affordability, our experts tackle your biggest pharmacy challenges.
Pharmacy benefit managers add value lower costs
PBMs don’t cause high drug costs — they’re part of the solution. Our drug prices beat the “low cost” vendors.
8 ways to make drugs more affordable
Discover what plan sponsors need to know to help remove or limit cost as a barrier to medication access.
The dangers of polypharmacy
Millions of workers at risk due to overprescribed drugs.
Pharmacy Insights Podcast
Listen to our resident experts discuss critical industry challenges and the solutions you need to control rising drug costs.
Drug pricing spotlight: Wound care
Combat against brand name products costing 125 times more.
6 thoughts: Shipping refrigerated medications
See how temperature-sensitive medications are protected in transit with Optum Rx.
Orphan drug market: Rare diseases, large costs
Orphan drugs offer hope to people with rare diseases. They also add large costs. Our Orphan Drug Program is a targeted strategy to help control costs.
Regulations to watch: Spring 2024
Get the latest on legislation impacting PBM operations.
3 ways to beat vaccine fatigue
Learn about researched vaccine messaging themes and important steps you can take to promote critical vaccinations for members.
The latest PBM regulations: Summer 2024
Get your guide to the evolving health care regulatory landscape and see what’s coming as lawmakers debate 600+ new bills impacting PBMs.
Specialty drugs: Not just set and forget?
For optimizing specialty drug therapy, monitoring patients throughout their care is key to cost-effective use of high-cost drugs.
Taking the paper out of member communications
Discover how digital communications can increase member engagement and lower the cost of care.
New innovative treatments for hemophilia B, RSV and COPD
Cutting-edge research in gene therapy, mRNA editing and blood enzymes pays off with powerful new advances for these drug classes.
Top 4 drug spend categories
Many patients combined with expensive drugs leads to top spending classes.
Get immediate savings on specialty drugs
Specialty drug spend is a “top threat” to employer-provided benefits. Discover sustainable savings with your existing Optum Rx plan.
Avoid surprises in pharmacy spend
Old strategies and new challenges don’t mix. Future-proof your plan and get better predictability with new pricing models and risk management tools.
Building the PBM of the future
The solutions plan sponsors need today to tackle the pharmacy challenges of tomorrow.
Advanced Pharmacy Audit Services
See how a health plan used advanced audit services to prevent and detect pharmacy fraud, saving over $1 million.
Fighting fraud how plan sponsor recovered funds
How one plan sponsor recovered $315,000 in six months.
Managing diabetes gains an 8:1 ROI
Learn how a third-party administrator’s client improved health outcomes and lowered costs.
Empowering clients with choice and transparency
Helping make prescription drugs more affordable for plan sponsors and the members we serve is a universal focus.
Smart formulary management
Develop and manage formularies that bring clinical and financial value.
4 myths: Carving out specialty pharmacy
Integrating specialty pharmacy means better care, lower costs.
Making sense of copay cards
Discover how copay cards can disrupt your benefit strategy.
Biosimilars to save billions in this decade
Prices for popular brand-name biologics drop up to 60% with generic-equivalent biosimilars.
3 ways to deal with escalating drug costs
Explore innovations custom built for today’s specialty challenges.
A young patient’s hemophilia story
See how Optum Rx helped change a patient’s life with access to life-altering medicines.
3 steps to slash medication costs
This is your employer guide to reducing your healthcare spending.
Winter: First big drugs of 2024
New treatments for NASH, schizophrenia and more are on the way.
Make your pharmacy benefit plan work better
Learn 4 key questions you should be asking.
Gene therapies: Can we afford the future of medicine?
Learn how to manage financial risk as gene therapies become more commonplace.
How to contain GLP-1 costs
Get strategies for handling the new anti-obesity medications.
Alternative funding: Real savings or problems?
See how much "free" drugs will actually cost you.
Creating connections through partnership
Hear from an Optum Rx client on how we're partnering together for everyone we serve.
The secret to lowering the total cost of care
Rising pharmacy costs concern everyone. Managing the underlying health conditions behind each prescription is key to addressing these high costs.
Optum Rx customer obsession
Watch how one Optum Rx employee made the system work better for everyone.
How to manage blockbuster anti-obesity drugs
The pricey weight management drugs work well, but users need coaching and support to maintain the benefits.
4 key forces shaping the future of pharmacy
These emerging trends will help define the road ahead.
How to eliminate prescription waste
Achieve savings by targeting expensive, low-value drugs.
How to manage medication overload
Hear from a leader's perspective on how to manage polypharmacy.
Alzheimer's treatment: Time for a level-set?
See success rates, risks and costs of the new Alzheimer’s treatments.
A seamless pharmacy benefit change?
We guarantee it. And it's easier than you think.
The new drugs plan sponsors need to watch for
See which trends to consider when assessing the pharmacy benefit, which new drugs may be flying under the radar and what's coming.
Orphan drugs market: Can we afford them?
We examine key questions around orphan drugs such as why they're so expensive, how they're being used and what plan sponsors should do next.
Pharmacy legislative rules fall 2024
An assessment of the latest rules impacting PBMs from state and federal legislation.
New treatments for rare and common conditions
Our report emphasizes new, next-gen and first-in-class treatments for cystic fibrosis, non-opioid treatment and GLP-1 drugs.
How our medication packaging helps the planet
Our eco-friendly, fully sustainable prescription packaging eliminates polystyrene and reduces CO2, water and plastic waste.
Insights on GLP-1s: Costs and coverage
Balancing the risks and the benefits of GLP-1 drugs.
Biosimilars: Hard to make but lower costs
Biosimilars compete with expensive biologic drugs by offering the same safety and effectiveness, but at a lower cost.
New options to treat schizophrenia, COPD
A clever combination drug offers new help for schizophrenia with reduced side effects, while Dupixent expands its footprint to COPD.
5 questions on health equity
Creating better health care access for all is a priority.
The state of pharmacy regulations
In this conversation, learn the implications of new pharmacy legislation and rulemaking, and how you can manage your benefits effectively.
Aging workforce and the impact on drug spend
An estimated 23% of the workforce will be over age 65 by 2050 – but what does that mean for my drug plan?
Automating the prior authorization process
Discover our latest innovation to the PA process — PreCheck Prior Authorization — which reduces approval times, appeals and denials.
How to push back on 3 key pharmacy headwinds
Innovative formulary structures and clinical programs can help plan sponsors meet the challenge of expensive orphan, biologic and GLP-1 drugs.
2024 in review
Another busy year in pharmacy is coming. Read about top stories in GLP-1s, biosimilars, top spend classes, key regulations and innovations.
Key new drugs help close out 2024
New biologics for breast cancer, hemophilia, and a rare form of heart disease are poised to add competition and choice in these classes.
Preparing your plan for the GLP-1 era
After revolutionizing care for diabetes and weight loss, GLP-1 drugs are being eyed for more. Can we afford it?
Are your pharmacy benefits working hard enough?
Pharmacy benefits should be transparent, affordable and easy to use. Get clear on your pharmacy benefit manager’s value with these 3 questions.
A quarter-century of pharmacy benefit changes
Explore the dramatic changes in the years since 2000 — in drug performance and design, and especially affordability.
Transform your pharmacy benefits with end-to-end transparency
Pharmacy benefits should be clear and simple. Are they? In this latest e-book, see how true transparency drives better outcomes.
New pharmacy benefit solutions to help bend the cost curve
In this conversation, get a peek into upcoming solutions and technologies designed to address high-cost medications.
![A Quarter-Century of Pharmacy Benefit Changes [E-Book]](/content/dam/optum-dam/images/business/pharmacy/hand-with-vial-1080x720.jpg)
![New Options to Treat Schizophrenia, COPD [Report]](/content/dam/o4-dam/images/professionals/pharmacies/clinician-on-ipad-with-microscope-1080x720.jpg)
